These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Silencing of R-Spondin1 increases radiosensitivity of glioma cells. Gu X; Wang X; Xiao H; Ma G; Cui L; Li Y; Zhou H; Liang W; Zhao B; Li K Oncotarget; 2015; 6(12):9756-65. PubMed ID: 25865226 [TBL] [Abstract][Full Text] [Related]
66. Aspirin-/TMZ-coloaded microspheres exert synergistic antiglioma efficacy via inhibition of β-catenin transactivation. Shi ZD; Qian XM; Liu CY; Han L; Zhang KL; Chen LY; Zhang JX; Pu PY; Yuan XB; Kang CS; CNS Neurosci Ther; 2013 Feb; 19(2):98-108. PubMed ID: 23230963 [TBL] [Abstract][Full Text] [Related]
67. N-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomide. Tang JB; Svilar D; Trivedi RN; Wang XH; Goellner EM; Moore B; Hamilton RL; Banze LA; Brown AR; Sobol RW Neuro Oncol; 2011 May; 13(5):471-86. PubMed ID: 21377995 [TBL] [Abstract][Full Text] [Related]
68. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy. Lin CJ; Lee CC; Shih YL; Lin TY; Wang SH; Lin YF; Shih CM Free Radic Biol Med; 2012 Jan; 52(2):377-91. PubMed ID: 22094224 [TBL] [Abstract][Full Text] [Related]
70. Heparanase confers temozolomide resistance by regulation of exosome secretion and circular RNA composition in glioma. Si J; Li W; Li X; Cao L; Chen Z; Jiang Z Cancer Sci; 2021 Sep; 112(9):3491-3506. PubMed ID: 34036683 [TBL] [Abstract][Full Text] [Related]
71. The CHAC1-inhibited Notch3 pathway is involved in temozolomide-induced glioma cytotoxicity. Chen PH; Shen WL; Shih CM; Ho KH; Cheng CH; Lin CW; Lee CC; Liu AJ; Chen KC Neuropharmacology; 2017 Apr; 116():300-314. PubMed ID: 27986595 [TBL] [Abstract][Full Text] [Related]
72. TMZ-induced PrPc/par-4 interaction promotes the survival of human glioma cells. Zhuang D; Liu Y; Mao Y; Gao L; Zhang H; Luan S; Huang F; Li Q Int J Cancer; 2012 Jan; 130(2):309-18. PubMed ID: 21328340 [TBL] [Abstract][Full Text] [Related]
73. Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or temozolomide in vitro. Maurer GD; Tritschler I; Adams B; Tabatabai G; Wick W; Stupp R; Weller M Neuro Oncol; 2009 Dec; 11(6):747-56. PubMed ID: 19221171 [TBL] [Abstract][Full Text] [Related]
74. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors. Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243 [TBL] [Abstract][Full Text] [Related]
75. Characterization of a side population of astrocytoma cells in response to temozolomide. Chua C; Zaiden N; Chong KH; See SJ; Wong MC; Ang BT; Tang C J Neurosurg; 2008 Nov; 109(5):856-66. PubMed ID: 18976075 [TBL] [Abstract][Full Text] [Related]
76. Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway. Han S; Li Z; Master LM; Master ZW; Wu A Br J Cancer; 2014 Sep; 111(7):1400-9. PubMed ID: 25093489 [TBL] [Abstract][Full Text] [Related]
77. MiR-136 modulates glioma cell sensitivity to temozolomide by targeting astrocyte elevated gene-1. Wu H; Liu Q; Cai T; Chen YD; Liao F; Wang ZF Diagn Pathol; 2014 Sep; 9():173. PubMed ID: 25266957 [TBL] [Abstract][Full Text] [Related]
78. Knockdown of Nrf2 enhances autophagy induced by temozolomide in U251 human glioma cell line. Zhou Y; Wang HD; Zhu L; Cong ZX; Li N; Ji XJ; Pan H; Wang JW; Li WC Oncol Rep; 2013 Jan; 29(1):394-400. PubMed ID: 23128449 [TBL] [Abstract][Full Text] [Related]
79. Bak and Mcl-1 are essential for Temozolomide induced cell death in human glioma. Gratas C; Séry Q; Rabé M; Oliver L; Vallette FM Oncotarget; 2014 May; 5(9):2428-35. PubMed ID: 24811082 [TBL] [Abstract][Full Text] [Related]
80. β-Asarone promotes Temozolomide's entry into glioma cells and decreases the expression of P-glycoprotein and MDR1. Wang N; Zhang Q; Ning B; Luo L; Fang Y Biomed Pharmacother; 2017 Jun; 90():368-374. PubMed ID: 28380412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]